• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在年龄、体重指数和抗血栓治疗类型匹配的女性和男性中,经皮冠状动脉介入治疗后的出血。

Bleeding after percutaneous coronary intervention in women and men matched for age, body mass index, and type of antithrombotic therapy.

机构信息

Deutsches Herzzentrum München, Munich, Germany.

出版信息

Am Heart J. 2013 Sep;166(3):534-40. doi: 10.1016/j.ahj.2013.07.006. Epub 2013 Aug 6.

DOI:10.1016/j.ahj.2013.07.006
PMID:24016504
Abstract

BACKGROUND

Factors underlying the increased risk of bleeding after percutaneous coronary intervention (PCI) in women compared with men remain incompletely understood.

METHODS

The study included 3,351 women and 3,351 men matched for age, body mass index, and type of antithrombotic therapy. Bleeding within the 30 days after PCI was defined using the Bleeding Academic Research Consortium criteria. The main outcome was 1-year mortality.

RESULTS

Bleeding occurred in 518 women and 354 men (15.5% vs 10.6%, odds ratio [OR] 1.55, 95% CI 1.34-1.79, P < .001). Severe (Bleeding Academic Research Consortium class ≥2) bleeds (9.4% vs 6.5%, P < .001) and access site bleeds (10.1% vs 5.4%, P < .001) were more common in women. After adjustment, female sex remained an independent correlate of any bleeding (adjusted OR 1.61 [1.35-1.92], P < .001) and access site (adjusted OR 2.00 [1.59-2.50], P < .001) but not of nonaccess site (adjusted OR 1.18 [0.91-1.54], P = .205) bleeding. There were 248 deaths: 32 deaths among men with bleeding versus 107 deaths among men with no bleeding (9.1% vs 3.6%, OR 2.68 [1.78-4.05], P < .001) and 40 deaths among women with bleeding vs 69 deaths among women with no bleeding (7.8% vs 2.5%, OR 3.35 [2.24-5.01], P < .001). No difference in mortality was observed among women and men who bled (P = .487). Bleeding was independently associated 1-year mortality (adjusted hazard ratio 2.18 [1.68-2.84], P < .001) with no bleeding-by-sex interaction (P = .439).

CONCLUSIONS

Despite matching for age, body mass index, and type of antithrombotic therapy, bleeding risk after PCI remained significantly higher in women than in men. Bleeding was associated with increased risk of 1-year mortality with no bleeding-by-sex interaction.

摘要

背景

与男性相比,女性经皮冠状动脉介入治疗(PCI)后出血风险增加的相关因素仍不完全清楚。

方法

该研究纳入了 3351 名女性和 3351 名年龄、体重指数和抗血栓治疗类型相匹配的男性。使用出血学术研究联合会(BARC)标准定义 PCI 后 30 天内的出血。主要结局为 1 年死亡率。

结果

518 名女性和 354 名男性发生出血(15.5% vs 10.6%,比值比[OR] 1.55,95%置信区间[CI] 1.34-1.79,P<.001)。严重出血(BARC 分级≥2)(9.4% vs 6.5%,P<.001)和入路部位出血(10.1% vs 5.4%,P<.001)在女性中更为常见。调整后,女性仍然是任何出血(调整 OR 1.61 [1.35-1.92],P<.001)和入路部位出血(调整 OR 2.00 [1.59-2.50],P<.001)的独立相关因素,但不是非入路部位出血(调整 OR 1.18 [0.91-1.54],P=0.205)的独立相关因素。共有 248 例死亡:出血男性 32 例,无出血男性 107 例(9.1% vs 3.6%,OR 2.68 [1.78-4.05],P<.001),出血女性 40 例,无出血女性 69 例(7.8% vs 2.5%,OR 3.35 [2.24-5.01],P<.001)。出血女性和男性的死亡率无差异(P=0.487)。出血与 1 年死亡率独立相关(调整后的危险比 2.18 [1.68-2.84],P<.001),出血性别间无交互作用(P=0.439)。

结论

尽管在年龄、体重指数和抗血栓治疗类型方面进行了匹配,但女性 PCI 后出血风险仍明显高于男性。出血与 1 年死亡率增加相关,且出血性别间无交互作用。

相似文献

1
Bleeding after percutaneous coronary intervention in women and men matched for age, body mass index, and type of antithrombotic therapy.在年龄、体重指数和抗血栓治疗类型匹配的女性和男性中,经皮冠状动脉介入治疗后的出血。
Am Heart J. 2013 Sep;166(3):534-40. doi: 10.1016/j.ahj.2013.07.006. Epub 2013 Aug 6.
2
Procedure-related bleeding in elective percutaneous coronary interventions.择期经皮冠状动脉介入治疗中的与操作相关的出血。
Eur J Clin Invest. 2015 Mar;45(3):263-73. doi: 10.1111/eci.12408. Epub 2015 Feb 14.
3
Relation of body mass index to bleeding during percutaneous coronary interventions.体重指数与经皮冠状动脉介入治疗期间出血的关系。
Am J Cardiol. 2015 Feb 15;115(4):434-40. doi: 10.1016/j.amjcard.2014.11.022. Epub 2014 Nov 29.
4
Differences in sex-related bleeding and outcomes after percutaneous coronary intervention: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) registry.经皮冠状动脉介入治疗后与性别相关的出血及预后差异:来自密歇根蓝十字蓝盾心血管联盟(BMC2)注册研究的见解
Am Heart J. 2014 Oct;168(4):552-9. doi: 10.1016/j.ahj.2014.07.012. Epub 2014 Jul 25.
5
Age and sex differences in inhospital complication rates and mortality after percutaneous coronary intervention procedures: evidence from the NCDR(®).年龄和性别对经皮冠状动脉介入治疗术后住院并发症发生率和死亡率的影响:来自 NCDR(®)的证据。
Am Heart J. 2014 Mar;167(3):376-83. doi: 10.1016/j.ahj.2013.11.001. Epub 2013 Nov 7.
6
Correlates of poor outcome among patients with bleeding after coronary interventions.冠状动脉介入治疗后出血患者预后不良的相关因素。
Coron Artery Dis. 2014 Sep;25(6):456-62. doi: 10.1097/MCA.0000000000000126.
7
Comparison of incidence of bleeding and mortality of men versus women with ST-elevation myocardial infarction treated with fibrinolysis.比较接受纤溶治疗的 ST 段抬高型心肌梗死患者中男性与女性的出血发生率和死亡率。
Am J Cardiol. 2012 Feb 1;109(3):320-6. doi: 10.1016/j.amjcard.2011.09.012. Epub 2011 Nov 10.
8
Sex-related analysis of short- and long-term clinical outcomes and bleeding among patients treated with primary percutaneous coronary intervention: an evaluation of the RISK-PCI data.性别相关分析在接受直接经皮冠状动脉介入治疗的患者中的短期和长期临床结局和出血的影响:RISK-PCI 数据评估。
Can J Cardiol. 2013 Sep;29(9):1097-103. doi: 10.1016/j.cjca.2012.11.013. Epub 2013 Feb 23.
9
Antithrombotic therapy after coronary stenting in patients with nonvalvular atrial fibrillation.非瓣膜性心房颤动患者冠状动脉支架置入术后的抗血栓治疗。
Can J Cardiol. 2013 Feb;29(2):213-8. doi: 10.1016/j.cjca.2012.08.008. Epub 2012 Oct 22.
10
Major bleeding complicating contemporary primary percutaneous coronary interventions-incidence, predictors, and prognostic implications.当代直接经皮冠状动脉介入治疗相关的严重出血——发生率、预测因素及预后影响
Cardiovasc Revasc Med. 2009 Apr-Jun;10(2):88-93. doi: 10.1016/j.carrev.2008.08.001.

引用本文的文献

1
Italian Association of Hospital Cardiologists Position Paper 'Gender discrepancy: time to implement gender-based clinical management'.意大利医院心脏病专家协会立场文件《性别差异:是时候实施基于性别的临床管理了》
Eur Heart J Suppl. 2024 May 16;26(Suppl 2):ii264-ii293. doi: 10.1093/eurheartjsupp/suae034. eCollection 2024 Apr.
2
The prevalence of bleeding after percutaneous coronary interventions: A systematic review and meta-analysis.经皮冠状动脉介入治疗后出血的发生率:系统评价和荟萃分析。
Indian Heart J. 2024 Jan-Feb;76(1):16-21. doi: 10.1016/j.ihj.2024.01.009. Epub 2024 Jan 10.
3
Sex-Related Bleeding Risk in Acute Coronary Syndrome Patients Receiving Dual Antiplatelet Therapy with Aspirin and a P2Y12 Inhibitor.
急性冠状动脉综合征患者接受阿司匹林和 P2Y12 抑制剂双联抗血小板治疗的出血风险与性别相关。
Med Princ Pract. 2023;32(3):200-208. doi: 10.1159/000529863. Epub 2023 Mar 22.
4
Comparative effectiveness of initial computed tomography and invasive coronary angiography in women and men with stable chest pain and suspected coronary artery disease: multicentre randomised trial.初始计算机断层扫描与侵入性冠状动脉造影对稳定型胸痛且疑似冠心病的男性和女性的比较效果:多中心随机试验
BMJ. 2022 Oct 19;379:e071133. doi: 10.1136/bmj-2022-071133.
5
Efficacy and Safety of Ticagrelor Versus Prasugrel in Women and Men with Acute Coronary Syndrome: A Pre-specified, Sex-Specific Analysis of the ISAR-REACT 5 Trial.替格瑞洛与普拉格雷在急性冠状动脉综合征女性和男性患者中的疗效和安全性:ISAR-REACT 5 试验的预先设定的、基于性别的分析。
J Atheroscler Thromb. 2022 May 1;29(5):747-761. doi: 10.5551/jat.62776. Epub 2021 Apr 16.
6
Vascular Access-Related Complications in Women: Temporal Trends, Emerging Data, and the Current State of Interventional Cardiology Practice.女性血管通路相关并发症:时间趋势、新出现的数据以及介入心脏病学实践的现状。
Curr Atheroscler Rep. 2018 Jun 8;20(8):41. doi: 10.1007/s11883-018-0741-y.
7
Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D Study.HIV 阳性人群中心血管介入治疗的性别差异;D:A:D 研究。
J Int AIDS Soc. 2018 Mar;21(3). doi: 10.1002/jia2.25083.